Somerset Pharma Overview
- Year Founded
-
2015

- Status
-
Private
- Latest Deal Type
-
M&A
- (Cancelled)
- Financing Rounds
-
1
Somerset Pharma General Information
Description
Manufacturer of injectable and ophthalmic drugs intended to serve the healthcare sector. The company develops and markets sterile injectable and ophthalmic drugs for the U.S. marketplace.
Contact Information
Website
www.somersetpharma.comCorporate Office
- 300 Franklin Square Drive
- Somerset, NJ 08873
- United States
Corporate Office
- 300 Franklin Square Drive
- Somerset, NJ 08873
- United States
Somerset Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Somerset Pharma Comparisons
Industry
Financing
Details
Somerset Pharma Competitors (26)
One of Somerset Pharma’s 26 competitors is EyePoint Pharmaceuticals, a Corporation company based in Watertown, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
EyePoint Pharmaceuticals | Corporation | Watertown, MA | ||||
Novartis | Corporation | Basel, Switzerland | ||||
Abzena | Private Equity-Backed | Cambridge, United Kingdom | ||||
GSK | Corporation | Middlesex, United Kingdom | ||||
Santhera Pharmaceuticals | Private Debt Financed | Pratteln, Switzerland |
Somerset Pharma Patents
Somerset Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240252475-A1 | Tiotropium combination product compositions and related methods | Pending | 26-Jan-2023 | ||
US-20230338393-A1 | Ophthalmic gel compositions of bimatoprost and timolol and associated methods | Active | 21-Mar-2022 | ||
US-20230293541-A1 | Methods of treating ophthalmic conditions with enhanced penetration compositions of bimatoprost and timolol | Pending | 21-Mar-2022 | ||
US-20230293547-A1 | Enhanced penetration ophthalmic compositions of bimatoprost and timolol | Active | 21-Mar-2022 | ||
US-12042502-B2 | Enhanced penetration ophthalmic compositions of bimatoprost and timolol | Active | 21-Mar-2022 | A61K31/5575 |
Somerset Pharma FAQs
-
When was Somerset Pharma founded?
Somerset Pharma was founded in 2015.
-
Where is Somerset Pharma headquartered?
Somerset Pharma is headquartered in Somerset, NJ.
-
What industry is Somerset Pharma in?
Somerset Pharma’s primary industry is Pharmaceuticals.
-
Is Somerset Pharma a private or public company?
Somerset Pharma is a Private company.
-
What is the current valuation of Somerset Pharma?
The current valuation of Somerset Pharma is
. -
What is Somerset Pharma’s current revenue?
The current revenue for Somerset Pharma is
. -
Who are Somerset Pharma’s competitors?
EyePoint Pharmaceuticals, Novartis, Abzena, GSK, and Santhera Pharmaceuticals are some of the 26 competitors of Somerset Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »